PERCUTANEOUS CLOSURE OF PATENT FORAMEN OVALE AND ATRIAL SEPTAL DEFECT: STATE OF THE ART AND A CRITICAL APPRAISAL
|
|
- John Hensley
- 6 years ago
- Views:
Transcription
1 PERCUTANEOUS CLOSURE OF PATENT FORAMEN OVALE AND ATRIAL SEPTAL DEFECT: STATE OF THE ART AND A CRITICAL APPRAISAL Carmelo Cernigliaro Clinica San Gaudenzio Novara
2
3
4 Eco 2D e 3D
5 Eco Transesofageo
6 Large shunt with transcranial Doppler Souteyrand, G. et al. Eur J Echocardiogr : ; doi: /j.euje
7 Impianto di INTRASEPT
8 PFO: Clinical Presentation Migraine with or without aura STROKE or TIA Decompression sickness Plathypnea-orthodeoxia syndrome
9 Cephalalgia May;28(5): Epub 2008 Mar 17. Patent foramen ovale and migraine: a quantitative systematic review. Schwedt TJ, Demaerschalk BM, Dodick DW. A quantitative systematic review of 18 articles. The estimated strength of association between PFO and migraine, reflected by summary odds ratios (ORs), was 5.13 [95% confidence interval (CI) 4.67, 5.59], and between PFO and migraine with aura the OR was 3.21 (95% CI 2.38, 4.17). The association between migraine and PFO was OR 2.54 (95% CI 2.01, 3.08).
10
11
12
13 Stroke recurrence in patients with patent foramen ovale: the Lausanne Study. Lausanne Stroke with Paradoxal Embolism Study Group. Bogousslavsky J, Garazi S et al. Neurology. 1996;46: Patent foramen ovale (PFO) is more common in patients with stroke than in matched controls. We studied recurrences of stroke in 140 consecutive patients (mean age 44 +/- 14 years) with stroke and PFO admitted to a population-based primary-care center. During a mean follow-up of 3 years, the stroke or death rate was 2.4% per year, but only eight patients had a recurrent infarct (1.9% per year). This low rate of recurrence contrasted with the severity of initial stroke. Multivariate analysis showed that interatrial communication, a history of recent migraine, posterior cerebral artery territory infarct, and a coexisting cause of stroke were associated with recurrence In conclusion, our study shows that stroke associated with PFO is usually embolic, although a definite source cannot often be demonstrated.
14 Probability That Patients Will Remain Free from Recurrent Stroke or Transient Ischemic Attack (TIA), According to the Presence or Absence of Atrial Septal Abnormalities. Mas J et al. N Engl J Med 2001;345:
15 Kohei Hayashida, Journal of Nuclear Medicine 2001; 42 (6)
16
17
18
19
20
21 ESC Stockholm 2010 Residual shunt after percutaneous closure of a patent foramen ovale. Results of a 3-year follow-up study. Objectives: To assess residual shunt, adverse events, migraine disability, up to 7 years after a patent foramen ovale (PFO) closure.
22 Methods Between 2002 and 2009, 87 consecutive patients underwent bubble contrast echocardiography re-study to assess residual right-to-left shunt, 1 year after closure with a CARDIA PFO device. Transcranial doppler was performed at 6 months and at 1 year. Office visits or telephone contacts were obtained every 6 months during an observation period of 3.3±1.7 years (range, years).
23 Study population (87 patients) Age, y 48.2±14.7 History of ischemia: Sex Male 35.6% - stroke 55.2% Hypertension 37.9% - TIA 41.4% Dyslipidemia Coagulation defect Atrial septal aneurism 31.0% 3.4% 41.4% - IHD 3.4%
24 Migraine headache presentation 70% 60.9% 60% 50% 40% 21.8% 30% 17.3% 20% 10% 0% Migraine with Aura Migraine without aura Non migraineurs
25 Vascular stroke territory at MRI 70% 50.0% 60% 39.6% 50% 40% 30% 20% 10.4% 10% 0% Anterior Posterior Border zone
26 CARDIA DEVICE
27 Results Incidence of residual shunt at 1 year 33.3% effective closure residual shunt 66.7%
28 Results
29 Results Migraine resolution or relief vs residual shunt 80% 71.3% p= % 60% 46.6% no shunt 50% 40% p= % residual shunt 30% 20% 17.2% 10% 0% Resolution Relief
30 Adverse events Adverse events during the 3-year follow-up were: 5 TIAs and 1 surgical PFO closure redo for intractable migraine.
31 Results Aura and residual shunt were significantly associated with adverse events ADVERSE EVENTS: 40% 36.4% p=0.002 presence absence 35% 30% 25% 21.7% p= % 15% 10% 5% 3.3% 2.2% 0% Aura Residual shunt
32 CARDIA COMPLICATIONS: 4 out of 87 pts (4.6%) Oesophagus perforation: 1 Left auricola perforation and tamponade: 1 Inferior NSTEMI: 1 Femoral vein A-V Fistula: 1
33 Conclusions Residual shunt after PFO closure is associated with adverse events and persistent migraine disability.
34 Who should undergo PFO closure? Cryptogenic stroke with large PFO and ASA and spontaneous right to left shunt Cryptogenic stroke which recurs despite anticoagulant therapy Cryptogenic stroke which recurs and patient would not comply long term anticoagulation
35 Percutaneous device closure of patent foramen ovale for secondary stroke prevention. A CALL FOR COMPLETION OF RANDOMIZED CLINICAL TRIALS A science advisory from the American Heart Association/ American Stroke Association and the American College of Cardiology Foundation. The American Academy of Neurology affirms the value of this science advisory. O Gara et al. J Am Coll Cardiol 2009;53:
36
37
38
39
40
41
42
43
44
45
46
47 PERCUTANEOUS ASD CLOSURE NO ONE IS TOO OLD TO BE CLOSED
48
49
50
51 Territori cerebrali vascolari
Patent Foramen Ovale: Diagnosis and Treatment
Patent Foramen Ovale: Diagnosis and Treatment Anthony DeMaria Judy and Jack White Chair in Cardiology University of California, San Diego At one time or another a Grantee, Sponsored Speaker or Ad-hoc Consultant
More informationMigraine and Patent Foramen Ovale (PFO)
Migraine and Patent Foramen Ovale (PFO) Hans-Christoph Diener Senior Professor of Clinical Neurosciences Department of Neurology and Headache Center University Essen Topics Prevalence of PFO Is migraine
More informationPFO (Patent Foramen Ovale): Smoking Gun or an Innocent Bystander?
PFO (Patent Foramen Ovale): Smoking Gun or an Innocent Bystander? J Thompson Sullebarger, M.D. Florida Cardiovascular Institute University of South Florida Kris Letang Tedy Bruschi Bret Michaels The Atrial
More informationPFO Closure for the Management of Migraine and Stroke
PFO Closure for the Management of Migraine and Stroke Sun U. Kwon Department of Neurology, Asan Medical Center, UUMC Contents PFO & Migraine PFO causes Migraine or Not? PFO closure for Migraine PFO & Stroke
More informationFabien Praz, Andreas Wahl, Sophie Beney, Stephan Windecker, Heinrich P. Mattle*, Bernhard Meier
Procedural Outcome after Percutaneous Closure of Patent Foramen Ovale using the Amplatzer PFO Occluder Without Intra-Procedural Echocardiography in 1,000 Patients Fabien Praz, Andreas Wahl, Sophie Beney,
More informationI, (Issam Moussa) DO NOT have a financial interest/arrangement t/ t or affiliation with one or more organizations that could be perceived as a real
PFO Closure: Where We Are Going to after CLOSURE I Study? Issam D. Moussa, MD Professor of Medicine Chair, Division of Cardiovascular Diseases Mayo Clinic Jacksonville, Florida Disclosure Statement of
More informationGERIATRICS CASE PRESENTATION
GERIATRICS CASE PRESENTATION CASE 79 year old Patient X was admitted to hospital with SOB. He had a hx of sarcoidosis and asbestosis. Home oxygen requirement is 3-3.5litre. He was admitted, given ceftriaxone
More informationStroke and ASA / FO REBUTTAL
REBUTTAL Definition of an ischemic stroke Definition of a PFO Evidence for a causal role of PFO in stroke Evidence against a role of PFO in stroke Stroke recurrencies in stroke (PFO) patients Medical treatment
More informationPFO closure group total no. PFO closure group no. of males
Suppl Table. Characteristics of the five trials included in this meta-analysis. Trial name Device used for Definition of medical Primary Endpoint group total no. group no. of males group age (yrs) group
More informationWhy Treat Patent Forman Ovale
Why Treat Patent Forman Ovale Clifford J Kavinsky, MD, PHD Professor of Medicine and pediatrics Associate Director, Center for Congenital and Structural Heart Disease Rush University Medical Center Conclusions
More informationAntithrombotic Summit Basel 2012 Basel, 26. April Peter T. Buser Klinik Kardiologie Unviersitätsspital Basel
Antithrombotic Summit Basel 2012 Basel, 26. April 2012 Peter T. Buser Klinik Kardiologie Unviersitätsspital Basel Background stroke = third-leading cause of death among adults 1/5 of stroke survivors require
More informationPFO- To Close for Comfort. By: Vincent J.Caracciolo, MD FACC
PFO- To Close for Comfort By: Vincent J.Caracciolo, MD FACC PATENT FORAMEN OVALE PFO- congenital lesion that frequently persists into adulthood ( 25-30%)- autopsy and TEE studies. PFO prevalence higher
More informationPFO Management update
PFO Management update May 12, 2017 Peter Casterella, MD Swedish Heart and Vascular 1 PFO Update 2017: Objectives Review recently released late outcomes of RESPECT trial and subsequent FDA approval of PFO
More informationIndex. cardiology.theclinics.com. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Acute ischemic stroke TOAST classification of, 270 Acute myocardial infarction (AMI) cardioembolic stroke following, 207 208 noncardioembolic
More informationWhy Should We Treat PFO?
Why Should We Treat PFO? SCAI Interventional Cardiology Fellows Course December 7, 2012 Jonathan Tobis, MD Director of Interventional Cardiology UCLA Disclosures Jonathan Tobis, MD 1. A Principal Investigator
More informationPercutaneous closure of a patent foramen ovale after cryptogenic stroke
Neth Heart J (2018) 26:5 12 https://doi.org/10.1007/s12471-017-1063-3 POINT OF VIEW Percutaneous closure of a patent foramen ovale after cryptogenic stroke R. J. R. Snijder 1 M.J.Suttorp 1 J.M.tenBerg
More informationPatent Foramen Ovale Closure Without Echocardiographic Control: Use of Standby Intracardiac Ultrasound
JACC: CARDIOVASCULAR INTERVENTIONS VOL. 1, NO. 4, 2008 2008 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-8798/08/$34.00 PUBLISHED BY ELSEVIER INC. DOI: 10.1016/j.jcin.2008.05.006 Patent Foramen
More informationPFO Closure is a Therapy for Migraine PRO
PFO Closure is a Therapy for Migraine PRO Andrew Charles, M.D. Professor Director, UCLA Goldberg Migraine Program Meyer and Renee Luskin Chair in Migraine and Headache Studies Director, Headache Research
More informationCLOSE. Closure of Patent Foramen Ovale, Oral anticoagulants or Antiplatelet Therapy to Prevent Stroke Recurrence
CLOSE Closure of Patent Foramen Ovale, Oral anticoagulants or Antiplatelet Therapy to Prevent Stroke Recurrence Guillaume TURC, MD, PhD Paris Descartes University Sainte-Anne hospital Paris, France On
More informationCPAG Summary Report for Clinical Panel Patent Foramen Ovale Closure for Secondary Prevention of Cryptogenic Stroke
MANAGEMENT IN CONFIDENCE CPAG Summary Report for Clinical Panel Patent Foramen Ovale Closure for Secondary Prevention of Cryptogenic Stroke The Benefits of the Proposition Percutaneous Patent Foramen Ovale
More informationDevices for Stroke Prevention. Douglas Ebersole, MD Interventional Cardiology Watson Clinic LLP
Devices for Stroke Prevention Douglas Ebersole, MD Interventional Cardiology Watson Clinic LLP Overview Left Atrial Appendage Closure FDA Approved Watchman Investigational Amulet PFO Closure Atrial Fibrillation
More informationThe Patent Foramen Ovale A Preventable Stroke Etiology?! Brian Whisenant, M.D.
The Patent Foramen Ovale A Preventable Stroke Etiology?! Brian Whisenant, M.D. Conflict of Interest Statement I have a financial interest in Coherex Medical. Heart Disease and Stroke Statistics 2008 Update:
More informationRESPECT Safety Findings
CO-1 SCAI Town Hall Meeting Monday, October 31, 2016 Washington, DC RESPECT Safety Findings John D. Carroll, M.D., MSCAI Professor of Medicine Cardiology University of Colorado School of Medicine University
More informationPatent Foramen Ovale and Cryptogenic Stroke: Do We Finally Have Closure? Christopher Streib, MD, MS
Patent Foramen Ovale and Cryptogenic Stroke: Do We Finally Have Closure? Christopher Streib, MD, MS 11-8-18 Outline 1. Background 2. Anatomy of patent foramen ovale (PFO) 3. Relationship between PFO and
More informationRahul Jhaveri, M.D. The Heart Group of Lancaster General Health
Rahul Jhaveri, M.D. The Heart Group of Lancaster General Health INTRODUCTION Three recently published randomized controlled trials in The New England Journal of Medicine provide new information about closure
More informationClinical Commissioning Policy Statement: Patent Foramen Ovale (PFO) Closure. April Reference: NHSCB/A09/PS/a
Clinical Commissioning Policy Statement: Patent Foramen Ovale (PFO) Closure April 2013 Reference: NHSCB/A09/PS/a NHS Commissioning Board Clinical Commissioning Policy Statement: Patent Foramen Ovale (PFO)
More informationCryptogenic Stroke/PFO with Thrombophilia and VTE: Do We Know What To Do?
Cryptogenic Stroke/PFO with Thrombophilia and VTE: Do We Know What To Do? Robert J. Sommer, MD Columbia University Medical Center New York, NY Disclosure Statement of Financial Interest Within the past
More informationPATENT FORAMEN OVALE: UPDATE IN MANAGEMENT OF RECURRENT STROKE KATRINE ZHIROFF, MD, FACC, FSCAI LOS ANGELES CARDIOLOGY ASSOCIATES
PATENT FORAMEN OVALE: UPDATE IN MANAGEMENT OF RECURRENT STROKE KATRINE ZHIROFF, MD, FACC, FSCAI LOS ANGELES CARDIOLOGY ASSOCIATES OBJECTIVES Review social burden and epidemiology of stroke Gender disparities
More informationThe Relation of Migraine Headaches and Interatrial Shunts
PFO AND MIGRAINE HOSPITAL CHRONICLES 2006, SUPPLEMENT: 73 78 CARDIOLOGY UPDATE 2006 The Relation of Migraine Headaches and Interatrial Shunts Konstantinos G. Kappos, MD, Vassiliki Tsagou, MD, George Andrikopoulos,
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE INTERVENTIONAL PROCEDURES PROGRAMME Interventional procedure overview of percutaneous closure of patent foramen ovale for the secondary prevention
More informationDEBATE: PFO MANAGEMENT TO CLOSE OR NOT TO CLOSE. Matthew Starr, MD Stroke Attending
DEBATE: PFO MANAGEMENT TO CLOSE OR NOT TO CLOSE Matthew Starr, MD Stroke Attending DISCLOSURES None DEBATE Should PFO be closed? * * Sometimes yes THE CASE AGAINST PFO CLOSURE 1. Did the PFO cause the
More informationΓεώργιος Δ. Κατσιμαγκλής. Αν. Διευθυντής Καρδιολογικής ΚλινικήςΝΝΑ Διευθυντής Αιμοδυναμικού Εργαστηρίου ΝΝΑ
Γεώργιος Δ. Κατσιμαγκλής Αν. Διευθυντής Καρδιολογικής ΚλινικήςΝΝΑ Διευθυντής Αιμοδυναμικού Εργαστηρίου ΝΝΑ I have no disclosures ΣΥΧΝΟΤΗΤΑ An atrial septal defect (ASD) is a deficiency of the atrial septum.
More informationPatent foramen ovale (PFO) is composed of
PFO Closure for Prevention of Recurrent Cryptogenic Stroke The evidence base is here. BY JOHN F. RHODES, JR, MD Patent foramen ovale (PFO) is composed of overlapping portions of septum primum and septum
More informationSupplementary webappendix
Supplementary webappendix This webappendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Hart RG, Diener H-C, Coutts SB, et al,
More informationEvidence Based Stroke Update Ajay Bhalla Guy s and St Thomas Hospitals UK Stroke Forum
Evidence Based Stroke Update 2017 Ajay Bhalla Guy s and St Thomas Hospitals UK Stroke Forum Future is hard to predict.. Future is hard to predict.. Future is hard to predict.. Future is hard to predict..
More informationPFO CLOSURE: WHAT S NEW?
PFO CLOSURE: WHAT S NEW? 1. AHA rescinds major sections of 2018 AHA/ASA Stroke Guidelines 2. PFO closure is cost effective 3. Now 12 meta-analyses of PFO/Stoke RCT confirm PFO closure superiority 4. FDA
More informationFoam Sclerotherapy and Patent Foramen Ovale (PFO) Gillet J-L J L (France)
Foam Sclerotherapy and Patent Foramen Ovale (PFO) Gillet J-L J L (France) Abano Terme, October 2013 1 Definition PFO is an incomplete closure of the atrial septum that results in the creation of a flap
More informationCryptogenic Stroke: What Don t We Know. Siddharth Sehgal, MD Medical Director, TMH Stroke Center Tallahassee Memorial Healthcare
Cryptogenic Stroke: What Don t We Know Siddharth Sehgal, MD Medical Director, TMH Stroke Center Tallahassee Memorial Healthcare Financial Disclosures None Objectives Principles of diagnostic evaluation
More information2017 Cardiovascular Symposium CRYPTOGENIC STROKE: A CARDIOVASCULAR PERSPECTIVE DR. WILLIAM DIXON AND DR. VENKATA BAVAKATI SOUTHERN MEDICAL GROUP, P.A.
CRYPTOGENIC STROKE: 2017 Cardiovascular Symposium A CARDIOVASCULAR PERSPECTIVE DR. WILLIAM DIXON AND DR. VENKATA BAVAKATI SOUTHERN MEDICAL GROUP, P.A. CRYPTOGENIC STROKE CRYPTOGENIC: OF OBSCURE OR UNKNOWN
More informationDescription. Page: 1 of 23. Closure Devices for Patent Foramen Ovale and Atrial Septal Defects. Last Review Status/Date: December 2014
Last Review Status/Date: December 2014 Page: 1 of 23 Description Background Patent Foramen Ovale The foramen ovale, a component of fetal cardiovascular circulation, consists of a communication between
More informationA 29-Year-Old Man With Acute Onset Blurry Vision, Weakness, and Gait Abnormality
Clinical Case of the Month A 29-Year-Old Man With Acute Onset Blurry Vision, Weakness, and Gait Abnormality Deepu Thoppil, MD; Murtuza J. Ali, MD; Neeraj Jain, MD; Sanjay Kamboj, MD; Pramilla Subramaniam,
More informationCryptogenic Stroke: A logical approach to a common clinical problem
Cryptogenic Stroke: A logical approach to a common clinical problem Alphonse M. Ambrosia, DO, FACC Interventional Cardiologist CardioVascular Associates of Mesa Mesa, Arizona Speakers Bureau Boston Scientific
More informationHEADACHE & FACIAL PAIN SECTION
Pain Medicine 2014; 15: 2156 2160 Wiley Periodicals, Inc. HEADACHE & FACIAL PAIN SECTION Original Research Article An Association Between Migraines and Heart Anomalies True or False? A Heart Ultrasound
More informationBASIL D. THANOPOULOS MD, PhD Associate Professor Honorary Consultant, RBH, London, UK
TRANSCATHETER CLOSURE OF ATRIAL SEPTAL DEFECT AND PFO BASIL D. THANOPOULOS MD, PhD Associate Professor Honorary Consultant, RBH, London, UK TRANSCATHETER CLOSURE OF ATRIAL SEPTAL DEFECT AND PFO BASIL D.
More informationPRACTICAL NEUROLOGY. An endovascular device to close a patent foramen ovale: b. Patent foram Blackwell Publishing Ltd
4 PRACTICAL NEUROLOGY Patent foram An endovascular device to close a patent foramen ovale: b FEBRUARY 2003 5 Jean-Louis Mas Service de Neurologie, Hôpital Sainte-Anne, 1 rue Cabanis, 75674 Paris Cedex
More informationBenign Headache and Diagnosis Pathophysiology. Dr Andrew J Dowson Director of the King s Headache Service King s College Hospital London
Benign Headache and Diagnosis Pathophysiology Dr Andrew J Dowson Director of the King s Headache Service King s College Hospital London Case histories Case 1 Male, 46 y - Truck driver - Headaches since
More informationTranscatheter Closure of Cardiovascular Defects
Medical Coverage Policy Effective Date...11/15/2017 Next Review Date...11/15/2018 Coverage Policy Number... 0011 Transcatheter Closure of Cardiovascular Defects Table of Contents Related Coverage Resources
More informationFORAME OVALE PERVIO E ICTUS CRIPTOGENETICO: Dimensione del problema. Roberto Mantovan, MD, PhD U.O. Cardiologia Ospedale M.
FORAME OVALE PERVIO E ICTUS CRIPTOGENETICO: Dimensione del problema Roberto Mantovan, MD, PhD U.O. Cardiologia Ospedale M. Bufalini - Cesena FORAME OVALE PERVIO ICTUS CRIPTOGENETICO FORAME OVALE PERVIO
More informationCryptogenic Stroke and Migraine Headache: The Clinical Cardiologist s View
CRYPTOGENIC STROKE, MIGRAINE & PFO HOSPITAL CHRONICLES 2006, SUPPLEMENT: 67 72 CARDIOLOGY UPDATE 2006 Cryptogenic Stroke and Migraine Headache: The Clinical Cardiologist s View Harold L. Kennedy, MD A
More informationUpdate interventional Cardiology Hans Rickli St.Gallen
Update interventional Cardiology 2012 Hans Rickli St.Gallen 26.11.2012 Review of Literature ESC-Highlights TCT/AHA-Highlights Update interventional cardiology 2012 Structural Heart Disease Transcatheter
More informationTranscatheter Closure of Septal Defects
Transcatheter Closure of Septal Defects Policy Number: 2.02.09 Last Review: 11/2018 Origination: 3/2007 Next Review: 11/2019 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide coverage
More informationClinical Policy: Transcatheter Closure of Patent Foramen Ovale Reference Number: CP.MP.151
Clinical Policy: Reference Number: CP.MP.151 Effective Date: 12/17 Last Review Date: 12/17 See Important Reminder at the end of this policy for important regulatory and legal information. Coding Implications
More informationIntracardiac echocardiography: an ideal guiding tool for device closure of interatrial communications
Eur J Echocardiography (2005) 6, 92e96 Intracardiac echocardiography: an ideal guiding tool for device closure of interatrial communications Thomas Bartel a, *, Thomas Konorza a, Ulrich Neudorf b, Tiko
More informationTranscatheter closure of patent foramen ovale using the internal jugular venous approach
New methods in diagnosis and therapy Transcatheter closure of patent foramen ovale using the internal jugular venous approach Przemysław Węglarz 1,2, Ewa Konarska-Kuszewska 2, Tadeusz Zębik 2, Piotr Kuszewski
More informationΔΙΑΧΕΙΡΙΣΗ ΑΣΘΕΝΩΝ ΜΕ ΜΕΣΟΚΟΛΠΙΚΗ ΕΠΙΚΟΙΝΩΝΙΑ ΖΑΧΑΡΑΚΗ ΑΓΓΕΛΙΚΗ ΚΑΡΔΙΟΛΟΓΟΣ ΗΡΑΚΛΕΙΟ - ΚΡΗΤΗ
ΔΙΑΧΕΙΡΙΣΗ ΑΣΘΕΝΩΝ ΜΕ ΜΕΣΟΚΟΛΠΙΚΗ ΕΠΙΚΟΙΝΩΝΙΑ ΖΑΧΑΡΑΚΗ ΑΓΓΕΛΙΚΗ ΚΑΡΔΙΟΛΟΓΟΣ ΗΡΑΚΛΕΙΟ - ΚΡΗΤΗ European Accreditation in TTE, TEE and CHD Echocardiography NOTHING TO DECLARE ATRIAL SEPTAL DEFECT TYPES SECUNDUM
More informationAtrial Septal Defect Closure. Stephen Brecker Director, Cardiac Catheterisation Labs
Stephen Brecker Director, Cardiac Catheterisation Labs ADVANCED ANGIOPLASTY Incorporating The Left Main 5 Plus Course Conflicts of Interest The following companies have supported educational courses held
More information2D/3D in Evaluation of Atrial Septum
2D/3D in Evaluation of Atrial Septum Roberto M Lang, MD OSTIUM SECUNDUM ASD: 2D AND 3D TNSESOPHAGEAL ECHO 1 Biplane views 90 0 3D Acquisi on Acquire 3D volume Lang RM et al. JASE 2012;25:3 46. Right atrial
More informationCEREBRO VASCULAR ACCIDENTS
CEREBRO VASCULAR S MICHAEL OPONG-KUSI, DO MBA MORTON CLINIC, TULSA, OK, USA 8/9/2012 1 Cerebrovascular Accident Third Leading cause of deaths (USA) 750,000 strokes in USA per year. 150,000 deaths in USA
More informationTrue cryptogenic stroke
True cryptogenic stroke Arne Lindgren, MD, PhD Dept of Clinical Sciences Lund, Neurology, Lund University Dept of Neurology and Rehabilitation Medicine Skåne University Hospital Lund, Sweden Disclosures
More informationIs Stroke a Paradoxical Embolism in Patients with Patent Foramen Ovale?
ORIGINAL ARTICLE Is Stroke a Paradoxical Embolism in Patients with Patent Foramen Ovale? Masahiro YASAKA, Ryoichi OTSUBO, Hiroshi OE and Kazuo MINEMATSU Abstract Objective Purpose was to assess the stroke
More informationTranscatheter Closure of Septal Defects
Transcatheter Closure of Septal Defects Policy Number: 2.02.09 Last Review: 11/2017 Origination: 3/2007 Next Review: 11/2018 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide coverage
More informationPatent foramen ovale morphology and stroke size
Priority Paper evaluation Patent foramen ovale morphology and stroke size Evaluation of: Akhondi A, Gevorgyan R, Tseng CH et al.: The Association of patent foramen ovale morphology and stroke size in patients
More informationEchocardiography Conference
Echocardiography Conference David Stultz, MD Cardiology Fellow, PGY-6 September 20, 2005 Atrial Septal Aneurysm Bulging of Fossa Ovalis Associated commonly with Atrial septal defect or small perforations
More informationCurrent management aspects in adult congenital heart disease: non-surgical closure of patent foramen ovale
Review Article Current management aspects in adult congenital heart disease: non-surgical closure of patent foramen ovale Kaivan Vaidya 1,2, Chinmay Khandkar 1,2, David Celermajer 1,2 1 Department of Cardiology,
More informationTRANSCATHETER CLOSURE OF ATRIAL SEPTAL DEFECT AND PFO
TRANSCATHETER CLOSURE OF ATRIAL SEPTAL DEFECT AND PFO BASIL D. THANOPOULOS MD, PhD Associate Professor Agios Loukas Clinic, Thessaloniki, Greece Ares Heart Center, Bucharest, Romania Honorary Consultant,
More informationACUTE CENTRAL PERIFERALEMBOLISM
EAE TEACHING COURSE 2010 Belgrade, Serbia October 22-23, 2010 ACUTE CENTRAL and PERIFERALEMBOLISM Maria João Andrade Lisbon, PT BACKGROUND Stroke is a leading cause of mortality and long-term disability
More informationESC Congress 2011 SIMULTANEOUS HYBRID REVASCULARIZATION OF CAROTID AND CORONARY DISEASE INITIAL RESULTS OF A NEW THERAPEUTIC APPROACH
ESC Congress 2011 SIMULTANEOUS HYBRID REVASCULARIZATION OF CAROTID AND CORONARY DISEASE IN PATIENTS WITH ACUTE CORONARY SYNDROME: INITIAL RESULTS OF A NEW THERAPEUTIC APPROACH AUTHORS: Marta Ponte 1, RICARDO
More informationAnaesthesia for percutaneous closure of atrial septal defects Patrick A Calvert BCh MA MRCP Andrew A Klein MBBS FRCA
Anaesthesia for percutaneous closure of atrial septal defects Patrick A Calvert BCh MA MRCP Andrew A Klein MBBS FRCA Key points Percutaneous closure is the procedure of choice for the majority of patients
More informationRequesting Adult Transthoracic Echocardiograms with Bubble Study
Requesting Adult Transthoracic Echocardiograms with Bubble Study Type: Clinical Guideline Register No: 11050 Status: Public Developed in response to: Contributes to CQC Core Outcome The need to prevent
More informationPatent foramen ovale (PFO) has been identified as a source
Percutaneous Transcatheter Closure of Patent Foramen Ovale in Patients With Paradoxical Embolism Francisco Martín, MD; Pedro L. Sánchez, MD; Elizabeth Doherty, MD; Pedro J. Colon-Hernandez, MD; Gabriel
More informationDiversion of the inferior vena cava following repair of atrial septal defect causing hypoxemia
Marshall University Marshall Digital Scholar Internal Medicine Faculty Research Spring 5-2004 Diversion of the inferior vena cava following repair of atrial septal defect causing hypoxemia Ellen A. Thompson
More informationJACC: CARDIOVASCULAR INTERVENTIONS VOL. 3, NO. 3, PUBLISHED BY ELSEVIER INC. DOI: /j.jcin
JACC: CARDIOVASCULAR INTERVENTIONS VOL. 3, NO. 3, 2010 2010 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-8798/10/$36.00 PUBLISHED BY ELSEVIER INC. DOI: 10.1016/j.jcin.2009.11.019 Primary
More informationPerspectives on PFO Closure: Clinical Trials for Stroke Prevention and Migraines
Perspectives on PFO Closure: Clinical Trials for Stroke Prevention and Migraines Mark Reisman,, MD Swedish Heart and Vascular Institute Seattle, Wa Disclosure National PI for the MIST trial- No financial
More informationTCT mdbuyline.com Clinical Trial Results Summary
TCT 2012 Clinical Trial Results Summary FAME2 Trial: FFR (fractional flow reserve) guided PCI in all target lesions Patients with significant ischemia, randomized 1:1 Control arm: not hemodynamically significant
More informationPatent Foramen Ovale and Cryptogenic Stroke in Older Patients
T h e n e w e ng l a nd j o u r na l o f m e dic i n e original article Patent Foramen Ovale and Cryptogenic Stroke in Older Patients Michael Handke, M.D., Andreas Harloff, M.D., Manfred Olschewski, M.Sc.,
More informationHow to manage the left subclavian and left vertebral artery during TEVAR
How to manage the left subclavian and left vertebral artery during TEVAR Jürg Schmidli Chief of Vascular Surgery Inselspital Hamburg 2017 Dept Cardiovascular Surgery, Bern, Switzerland Disclosure No Disclosures
More informationΣΥΓΚΛΕΙΣΗ ΑΝΟΙΚΤΟΥ ΩΟΕΙΔΟΥΣ ΤΡΗΜΑΤΟΣ ΠΕΣΡΟ. ΔΑΡΔΑ, MD, FESC 33 Ο Πανελλήνιο Καρδιολογικό Συνζδριο ΑΘΗΝΑ 2012
ΣΥΓΚΛΕΙΣΗ ΑΝΟΙΚΤΟΥ ΩΟΕΙΔΟΥΣ ΤΡΗΜΑΤΟΣ 2012 ΠΕΣΡΟ. ΔΑΡΔΑ, MD, FESC 33 Ο Πανελλήνιο Καρδιολογικό Συνζδριο ΑΘΗΝΑ 2012 The Problem: Not All PFO in Patients With Cryptogenic Stroke is Pathogenic; No Definitive
More informationNicolas Bianchi M.D. May 15th, 2012
Nicolas Bianchi M.D. May 15th, 2012 New concepts in TIA Differential Diagnosis Stroke Syndromes To learn the new definitions and concepts on TIA as a condition of high risk for stroke. To recognize the
More informationEffect of Having a PFO Occlusion Device in Place in the RESPECT PFO Closure Trial
Effect of Having a PFO Occlusion Device in Place in the RESPECT PFO Closure Trial DAVID E. THALER, MD, PHD, JEFFREY L. SAVER, MD RICHARD W. SMALLING, MD, PHD, JOHN D. CARROLL, MD, SCOTT BERRY, PHD, LEE
More informationSpeakers. 2015, American Heart Association 1
Speakers Lee Schwamm, MD, FAHA Executive Vice Chairman of Neurology, Massachusetts General Hospital Director, Stroke Service and Medical Director, MGH TeleHealth, Massachusetts General Hospital Director,
More informationUptofate Study Summary
CONGENITAL HEART DISEASE Uptofate Study Summary Acyanotic Atrial septal defect Ventricular septal defect Patent foramen ovale Patent ductus arteriosus Aortic coartation Pulmonary stenosis Cyanotic Tetralogy
More informationOcclusion de l'auricule gauche: Niche ou réel avenir? D Gras, MD, Nantes, France
Occlusion de l'auricule gauche: Niche ou réel avenir? D Gras, MD, Nantes, France LAA Occlusion Is there a real future? Background Protect AF Trial Other Studies CAP, ASAP, Prevail Left Atrial Appendage
More informationSupplementary appendix
Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Mazzucco S, Li L, Binney L, Rothwell PM. Prevalence
More informationLesion patterns in patients with cryptogenic stroke with and without right-to-left-shunt
European Journal of Neurology 2009, 16: 1077 1082 CME ARTICLE doi:10.1111/j.1468-1331.2009.02692.x Lesion patterns in patients with cryptogenic stroke with and without right-to-left-shunt R. Feurer a,
More informationMigraine and Risk of Stroke in Young Women
A Peer Reviewed Publication of the College of Allied Health & Nursing at Nova Southeastern University Dedicated to allied health professional practice and education http://ijahsp.nova.edu Vol. 5 No. 3
More informationEAE RECOMMENDATIONS FOR TRANSESOPHAGEAL ECHO. Cardiac Sources of Embolism. Luigi P. Badano, MD, FESC
EAE RECOMMENDATIONS FOR TRANSESOPHAGEAL ECHO. Cardiac Sources of Embolism Luigi P. Badano, MD, FESC Background Stroke is the 3 cause of death in several industrial countries; Embolism accounts for 15-30%
More informationTranscatheter Closure of Patent Foramen Ovale in Patients With Cerebral Ischemia
Journal of the American College of Cardiology Vol. 39, No. 12, 2002 2002 by the American College of Cardiology Foundation ISSN 0735-1097/02/$22.00 Published by Elsevier Science Inc. PII S0735-1097(02)01904-6
More informationIt has been 133 years since the German anatomist J.
PFO Closure to Prevent Recurrent TIA and Stroke What is the evidence base for patent foramen ovale closure? BY MICHAEL H. SALINGER, MD, FACC, FSCAI; MEHMET CILINGIROGLU, MD, FACC, FESC, FSCAI; JUSTIN P.
More informationThe influence of percutaneous atrial septal defect closure on the occurrence of migraine
European Heart Journal (2005) 26, 1533 1537 doi:10.1093/eurheartj/ehi170 Clinical research The influence of percutaneous atrial septal defect closure on the occurrence of migraine Katrin Mortelmans 1,
More informationIndex. interventional.theclinics.com. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Alagille syndrome, pulmonary artery stenosis in, 143 145, 148 149 Amplatz devices for atrial septal defect closure, 42 46 for coronary
More informationDirect oral anticoagulants for Embolic Strokes of Undetermined Source? George Ntaios University of Thessaly, Larissa/Greece
Direct oral anticoagulants for Embolic Strokes of Undetermined Source? George Ntaios University of Thessaly, Larissa/Greece Disclosures Scholarships: European Stroke Organization; Hellenic Society of Atherosclerosis.
More informationINSTRUCTIONS FOR USE FOR:
INSTRUCTIONS FOR USE FOR: en English bg INSTRUCTIONS FOR USE FOR: GORE CARDIOFORM SEPTAL OCCLUDER Carefully read all instructions prior to use. Observe all warnings and precautions noted throughout these
More informationCryptogenic Strokes: Evaluation and Management
Cryptogenic Strokes: Evaluation and Management 77 yo man with hypertension and hyperlipidemia developed onset of left hemiparesis and right gaze preference, last seen normal at 10:00 AM Brought to ZSFG
More informationAlan Barber. Professor of Clinical Neurology University of Auckland
Alan Barber Professor of Clinical Neurology University of Auckland Presented with L numbness & slurred speech 2 episodes; 10 mins & 2 hrs Hypertension Type II DM Examination pulse 80/min reg, BP 160/95
More informationOf the strokes that occur annually in the United
The Association of Patent Foramen Ovale Morphology and Stroke Size in Patients With Paradoxical Embolism Andre Akhondi, MD; Rubine Gevorgyan, MD; Chi-Hong Tseng, PhD; Leo Slavin, MD; Catherine Dao, MD;
More informationEmbolic stroke of unknown source (ESUS) in patients with atrial septum defect and patent foramen ovale: difference and similarities
Mémoire de Maîtrise en médecine No 2688 Embolic stroke of unknown source (ESUS) in patients with atrial septum defect and patent foramen ovale: difference and similarities Etudiant Constant Delabays Tuteur
More informationPermanent foramen ovale: when to close?
Permanent foramen ovale: when to close? Pierre Amarenco INSERM U-698 and Denis Diderot University - Paris VII Department of Neurology and Stroke Center Bichat hospital, Paris, France PFO - Pathology TEE
More informationManagement and Investigation of Ischemic Stroke By Etiology
Management and Investigation of Ischemic Stroke By Etiology Andrew M. Demchuk MD FRCPC Director, Calgary Stroke Program Deputy Dept Head, Clinical Neurosciences Heart and Stroke Foundation Chair in Stroke
More informationAVC Criptogénico: Está na altura de alterar as guidelines? Claudia Jorge University Hospital of Santa Maria
Está na altura de alterar as guidelines? Claudia Jorge University Hospital of Santa Maria Está na altura de alterar as guidelines? Está na altura de alterar as guidelines? ~25% of all ischemic strokes
More information